IP Library › Assignment 040398/0489
Patent Assignment
Reel/Frame 040398/0489

Merger

Recorded: 2016-11-22 Pages: 5
Assignor
DARWIN MOLECULAR CORPORATION
Executed: 2005-12-28
Assignee
UCB MANUFACTURING, INC.
755 JEFFERSON STREET, ROCHESTER, NEW YORK, 14623
Covered Properties (6)
Polynucleotides Encoding Antibodies Specific for Sclerostin
Application: 12/958,195 →
Publication: US 2011/0195453
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Application: 13/101,434 →
Publication: US 2011/0206677
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Application: 13/101,455 →
Publication: US 2011/0206678
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Patent: 8,563,271 →
Application: 13/592,116 →
Publication: US 2012/0321636
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Patent: 8,992,911 →
Application: 13/670,240 →
Publication: US 2013/0064829
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Patent: 9,011,856 →
Application: 13/670,259 →
Publication: US 2013/0064830
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 12, 2014
From: UCB MANUFACTURING, INC.
To: UCB PHARMA S.A.
Reel/Frame 033516/0493 →
Assignment of Assignor's Interest Nov 22, 2016
From: WINKLER, DAVID G.; SHI, JIYE; LATHAM, JOHN
To: CELLTECH R&D, INC.
Reel/Frame 040398/0431 →
Dissolution of Celltech R&D, Inc. and Subsequent Distribution of Assets into Darwin Molecular Corporation Nov 22, 2016
From: CELLTECH R&D, INC.
To: DARWIN MOLECULAR CORPORATION
Reel/Frame 040662/0916 →